Susquehanna Portfolio Strategies, LLC

Position in CYTK — Cytokinetics Inc

CIK 1996449 Bala Cynwyd, PA

Position in CYTK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,201,179

-$17,150,076 QoQ

Shares Held

14,100

-94.9% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#249

of 477 holders

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Susquehanna Portfolio Strategies, LLC holds $399,265,861 across 121 Biotechnology names. CYTK ranks #62 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	90,928	$45,166,665
2	MRNA	Moderna, Inc.	471,043	$32,987,141
3	CORT	Corcept Therapeutics Inc	211,017	$18,347,928
4	BBIO	BridgeBio Pharma, Inc.	226,869	$16,897,203
5	BMRN	Biomarin Pharmaceutical Inc	273,562	$15,653,217
6	HALO	Halozyme Therapeutics, Inc.	166,503	$13,032,189
7	EXEL	Exelixis, Inc.	229,749	$12,500,643
8	MDGL	Madrigal Pharmaceuticals, Inc.	22,003	$11,814,510

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,201,179	14,100	-94.9%	Shares	Sole	2026-08-14
2026-03-31	$18,351,255	278,429	0.0%	Shares	Sole	2026-05-15
2025-12-31	$17,691,378	278,429	0.0%	Shares	Sole	2026-02-17
2025-09-30	$15,302,457	278,429	+5.3%	Shares	Sole	2025-11-14
2025-06-30	$8,733,430	264,329	+1981.2%	Shares	Sole	2025-08-14
2024-09-30	$670,612	12,701	-61.6%	Shares	Defined	2024-11-14
2024-06-30	$1,791,786	33,071	0.0%	Shares	Defined	2024-08-15
2024-03-31	$2,318,607	33,071	0.0%	Shares	Defined	2024-05-07
2023-12-31	$2,761,097	33,071	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.